Breaking News Instant updates and real-time market news.

2022-01-20 15:16:23 CG Carlyle Group $51.64 / +1.05 (+2.08%) 15:16 01/20/22 01/20 15:16 01/20/22 15:16	Carlyle Group mulls sale of Titan acquisition, Bloomberg reports Carlyle Group is mulling a sale of Titan Acquisition and is collaborating with an adviser on a potential auction for the military contractor, Kiel Porter of Bloomberg reported, citing sources familiar with the matter. Titan is owned by Carlyle and Stellex Capital Management and reportedly could be valued at $2B. The company is likely to garner interest from other defense companies and private equity firms, according to the sources. Reference Link	16 Feb 12 Mar 19 May 10 Nov

2022-01-20 15:16:23

Carlyle Group

$51.64 / +1.05 (+2.08%)

15:16

01/20/22

01/20

15:16

01/20/22

15:16

Carlyle Group mulls sale of Titan acquisition, Bloomberg reports

Carlyle Group is mulling a sale of Titan Acquisition and is collaborating with an adviser on a potential auction for the military contractor, Kiel Porter of Bloomberg reported, citing sources familiar with the matter. Titan is owned by Carlyle and Stellex Capital Management and reportedly could be valued at $2B. The company is likely to garner interest from other defense companies and private equity firms, according to the sources. Reference Link

16
Feb

12
Mar
19
May
10
Nov

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	Concert :THRIVE-AA1 study meets primary endpoint for scalp hair regrowth » 07:20 05/23/22 05/23 07:20 05/23/22 07:20 CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) Concert Pharmaceuticals… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 01/04/22 Concert Pharmaceuticals completes enrollment in THRIVE-AA2 trial CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 11/12/21 JMP Securities Concert Pharmaceuticals price target lowered to $10 from $17 at JMP Securities 10/05/21 Mizuho Concert Pharmaceuticals price target lowered to $9 from $13 at Mizuho CNCE Concert Pharmaceuticals $4.49 / + (+0.00%) 05/05/22 Concert Pharmaceuticals reports Q1 EPS ($1.03), consensus (91c) 03/03/22 Concert Pharmaceuticals reports Q4 EPS ($1.01), consensus (73c) 06/09/22 Concert Pharmaceuticals, Inc.
Hot Stocks	Jaguar Health announces launch of U.S. Canine Cancer Registry » 07:20 05/23/22 05/23 07:20 05/23/22 07:20 JAGX Jaguar Health / + Jaguar Health, announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options JAGX Jaguar Health / + 05/11/22 Jaguar Health announces launch of Mytesi telehealth program 05/03/22 Jaguar Health files for conditional new animal drug approval of Canalevia 04/27/22 Jaguar Health announces commercial availability of Canalevia-CA1 04/05/22 Jaguar Health appoints Pravin Chaturvedi as CSO, chair of SAB JAGX Jaguar Health / + 07/07/21 Fly Intel: Top five analyst initiations 07/07/21 Cantor Fitzgerald Jaguar Health initiated with an Overweight at Cantor Fitzgerald JAGX Jaguar Health / + 05/10/22 Jaguar Health reports Q1 EPS (40c) vs. (28c) last year 06/10/22 Jaguar Health Inc. JAGX Jaguar Health / + 01/14/22 Largest borrow rate increases among liquid names
Hot Stocks	Biohaven Pharmaceutical provides update on Phase 3 troriluzole trial in SCA » 07:19 05/23/22 05/23 07:19 05/23/22 07:19 BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) Biohaven Pharmaceutical… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 Biohaven Pharmaceutical rises 70.2% 05/10/22 Biohaven Pharmaceutical rises 70.8% 05/10/22 Biohaven Pharmaceutical rises 70.7% 05/10/22 Pfizer to acquire Biohaven Pharmaceuticals for $148.50 per share BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/11/22 H.C. Wainwright Biohaven Pharmaceutical downgraded to Neutral from Buy at H.C. Wainwright 05/11/22 Wedbush Global Blood Therapeutics added to Best Ideas List at Wedbush 05/02/22 Piper Sandler Piper sees 'outright misinformation' on Biohaven, says buy shares 04/22/22 Piper Sandler Biohaven widening lead over AbbVie in migraine, says Piper Sandler BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 Biohaven Pharmaceutical sees 2022 net product sales $825M-$900M 05/10/22 Biohaven Pharmaceutical reports Q1 EPS ($2.97), consensus ($2.53) 02/25/22 Biohaven Pharmaceutical reports Q4 adjusted EPS ($2.32), consensus ($2.04) BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 01/13/22 Biogen working with Goldman to explore possible acquisitions, STAT says BHVN Biohaven Pharmaceutical $141.80 / +0.72 (+0.51%) 05/10/22 What You Missed On Wall Street On Tuesday 05/10/22 What You Missed On Wall Street This Morning 05/10/22 Fly Intel: Pre-market Movers 01/13/22 Wall Street in Fives - Must Read Lists for Thursday
Hot Stocks	Kaman to acquire Parker-Hannifin aircraft wheel & brake division for $440M » 07:18 05/23/22 05/23 07:18 05/23/22 07:18 KAMN Kaman $32.87 / -0.725 (-2.16%) , PH Parker-Hannifin $258.80 / -4.05 (-1.54%) Kaman (KAMN) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 07:06 Today Parker-Hannifin to divest Aircraft Wheel, Brake Division to Kaman 05/02/22 Kaman maintains FY guidance 04/20/22 Kaman announces $50M share repurchase program 03/07/22 Kaman gets follow-up award for HH-60W combat rescue helicopter cockpits PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 07:06 Today Parker-Hannifin to divest Aircraft Wheel, Brake Division to Kaman 04/28/22 Parker-Hannifin increases quarterly cash dividend 29% to $1.33 per share 04/11/22 Parker-Hannifin says European Commission clears acquisition of Meggitt 04/05/22 Parker-Hannifin says third party gained unauthorized access to company's systems KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/04/22 KeyBanc Kaman price target lowered to $45 from $52 at KeyBanc 02/28/22 KeyBanc Kaman price target lowered to $52 from $59 at KeyBanc 06/23/21 KeyBanc Kaman price target lowered to $59 from $65 at KeyBanc PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 05/06/22 Mizuho Parker-Hannifin price target lowered to $290 from $305 at Mizuho 04/18/22 Stifel Parker-Hannifin price target lowered to $338 from $384 at Stifel 04/14/22 Deutsche Bank Parker-Hannifin price target lowered to $335 from $343 at Deutsche Bank 04/04/22 Barclays Parker-Hannifin price target lowered to $350 from $376 at Barclays KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/02/22 Kaman reports Q1 adjusted EPS 15c vs. 29c last year 02/24/22 Kaman reports Q4 adjusted EPS 48c, consensus 47c PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 05/05/22 Parker-Hannifin updates FY22 adjusted EPS view $18.00-$18.30 from $17.80-$18.30 05/05/22 Parker-Hannifin reports Q3 adjusted EPS $4.83, consensus $4.65 02/03/22 Parker-Hannifin raises FY22 adjusted EPS view $17.80-$18.30 from $16.95-$17.65 02/03/22 Parker-Hannifin reports Q2 adjusted EPS $4.46, consensus $3.91 PH PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 04/01/22 EU regulators set to clear Parker-Hannifin's bid for Meggitt, Reuters says 04/01/22 EU antitrust regulators to approve Parker-Hannifin bid for Meggitt, Reuters says KAMN PH KAMN Kaman $32.87 / -0.725 (-2.16%) 05/02/22 Fly Intel: After-Hours Movers PH Parker-Hannifin $258.80 / -4.05 (-1.54%) 04/01/22 What You Missed On Wall Street On Friday 04/01/22 What You Missed On Wall Street This Morning
Hot Stocks	Parsons to acquire Xator Corporation in $343M transaction » 07:18 05/23/22 05/23 07:18 05/23/22 07:18 PSN Parsons $36.24 / +0.365 (+1.02%) Parsons Corporation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PSN Parsons $36.24 / +0.365 (+1.02%) 05/18/22 Parsons announces Parsons X approach 04/22/22 Parsons releases 2022 ESG report 04/13/22 Parsons completes critical design review for directed energy system 03/31/22 Parsons to highlight space domain capabilities at Space Symposium PSN Parsons $36.24 / +0.365 (+1.02%) 04/22/22 Truist Parsons downgraded to Hold from Buy at Truist 03/17/22 Stifel Parsons resumed with a Buy at Stifel 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA 03/11/22 BofA Parsons upgraded to Neutral from Underperform at BofA PSN Parsons $36.24 / +0.365 (+1.02%) 05/04/22 Parsons backs 2022 revenue view $3.7B-$3.9B, consensus $3.8B 05/04/22 Parsons reports Q1 adjusted EPS 40c, consensus 38c 02/23/22 Parsons sees 2022 revenue $3.7B-$3.9B, consensus $3.79B 02/23/22 Parsons reports Q4 adjusted EPS 55c, consensus 53c PSN Parsons $36.24 / +0.365 (+1.02%) 03/04/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/01/22 IT Services Summit 06/14/22 Aerospace, Defense & Airlines ESG Virtual Summit 08/08/22 7th Annual Wells Fargo FinTech & Technology Services Forum

Downgrade	Athersys downgraded to Underperform from Neutral at BofA » 07:17 05/23/22 05/23 07:17 05/23/22 07:17 ATHX Athersys / + BofA analyst Greg… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events Options ATHX Athersys / + 05/20/22 Athersys sinks after partner's stem-cell therapy study fails to meet endpoint 04/04/22 Athersys: Healios K.K. reports update on MultiStem programs in Japan 01/20/22 Athersys appoints Daniel Camardo as CEO 11/30/21 Athersys announces peer-reviewed publication of data from MUST-ARDS trial ATHX Athersys / + 07:13 Today BofA Correction: Athersys downgraded to Underperform from Neutral at BofA 11/19/21 BofA Athersys downgraded to Neutral from Buy at BofA (yesterday) ATHX Athersys / + 05/06/22 Athersys reports Q1 EPS (9c), consensus (10c) 03/15/22 Athersys reports Q4 EPS (9c), consensus (7c) 06/15/22 Athersys, Inc. ATHX Athersys / + 03/15/22 Athersys options imply 26.0% move in share price post-earnings 12/09/21 Largest borrow rate increases among liquid names 12/08/21 Largest borrow rate increases among liquid names 12/06/21 Largest borrow rate increases among liquid names
Recommendations	Compass Minerals price target lowered to $55 from $73 at Deutsche Bank » 07:17 05/23/22 05/23 07:17 05/23/22 07:17 CMP Compass Minerals $43.37 / -0.91 (-2.06%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Compass Minerals sees FY22 adjusted EBITDA $170M-$200M 04/12/22 Compass Minerals gets maximum payment from sale of specialty plant unit 04/11/22 Compass Minerals provides Q2 snow data and salt segment sales update 02/01/22 Compass Minerals to replace Great Western in S&P 600 at open on 2/1 CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/11/22 CL King Compass Minerals price target lowered to $52 from $67 at CL King 04/18/22 BMO Capital Compass Minerals price target raised to $63 from $60 at BMO Capital 03/03/22 CL King Compass Minerals price target raised to $67 from $65 at CL King 02/10/22 JPMorgan Compass Minerals downgraded to Underweight from Neutral at JPMorgan CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Compass Minerals reports Q2 adjusted EPS 33c, consensus 91c 02/08/22 Compass Minerals cuts FY22 adjusted EBITDA view to $200M-$235M 02/08/22 Compass Minerals reports Q1 adjusted EPS 38c, consensus 55c CMP Compass Minerals $43.37 / -0.91 (-2.06%) 05/05/22 Fly Intel: After-Hours Movers
Recommendations	Flowers Foods price target lowered to $26 from $27 at Deutsche Bank » 07:16 05/23/22 05/23 07:16 05/23/22 07:16 FLO Flowers Foods $26.52 / +1.34 (+5.32%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events FLO Flowers Foods $26.52 / +1.34 (+5.32%) 02/18/22 Flowers Foods increases quarterly dividend 5% to 21c per share 12/17/21 Flowers Foods recalls certain Nature's Own Honey Wheat bread sold in six states FLO Flowers Foods $26.52 / +1.34 (+5.32%) 11/15/21 Truist Flowers Foods price target raised to $30 from $25 at Truist 05/25/21 Stephens Flowers Foods assumed with an Equal Weight at Stephens 05/24/21 Deutsche Bank Flowers Foods price target lowered to $24 from $25 at Deutsche Bank FLO Flowers Foods $26.52 / +1.34 (+5.32%) 05/19/22 Flowers Foods lowers FY22 adjusted EPS view to $1.20-$1.30 from $1.25-$1.35 05/19/22 Flowers Foods reports Q1 adjusted EPS 44c, consensus 39c 02/10/22 Flowers Foods sees FY22 adjusted EPS $1.25-$1.35, consensus $1.27 02/10/22 Flowers Foods reports Q4 adjusted EPS 20c, consensus 21c FLO Flowers Foods $26.52 / +1.34 (+5.32%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/26/22 Flowers Foods, Inc.
Hot Stocks	Idaho Strategic adds Lemhi Pass Thorium Project » 07:16 05/23/22 05/23 07:16 05/23/22 07:16 IDR Idaho Strategic $7.10 / +0.08 (+1.14%) Idaho Strategic Resources… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings IDR Idaho Strategic $7.10 / +0.08 (+1.14%) 05/12/22 Idaho Strategic announces addition of Lemhi Pass REE project in Idaho 04/07/22 Idaho Strategic announces high-grade intercepts from Klondike Zone 03/15/22 Idaho Strategic announces participation in IGEM Project IDR Idaho Strategic $7.10 / +0.08 (+1.14%) 03/31/22 Idaho Strategic reports 2021 gold concentrate revenue $7.6M vs. $5.67M last year
Recommendations	Foot Locker price target raised to $32 from $30 at Deutsche Bank » 07:16 05/23/22 05/23 07:16 05/23/22 07:16 FL Foot Locker $31.52 / +1.22 (+4.03%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options FL Foot Locker $31.52 / +1.22 (+4.03%) 05/20/22 Foot Locker rises 9.5% 05/20/22 Foot Locker sees FY22 comparable sales down 8%-10% 05/05/22 Foot Locker, Adidas announce new long-term strategic partnership 03/24/22 Foot Locker targets net zero GHG emissions by 2050 or sooner FL Foot Locker $31.52 / +1.22 (+4.03%) 06:24 Today Baird Foot Locker price target raised to $32 from $30 05/16/22 Deutsche Bank Foot Locker price target lowered to $30 from $32 at Deutsche Bank 05/16/22 OTR Global Foot Locker downgraded to Mixed from Positive at OTR Global 03/28/22 Cowen Cowen cuts Foot Locker to Market Perform, more cautious following March data FL Foot Locker $31.52 / +1.22 (+4.03%) 05/20/22 Foot Locker backs FY22 EPS $4.25-$4.60, consensus $4.41 05/20/22 Foot Locker reports Q1 EPS $1.60, consensus $1.55 05/19/22 Notable companies reporting before tomorrow's open 05/19/22 Notable companies reporting before tomorrow's open FL Foot Locker $31.52 / +1.22 (+4.03%) 03/05/22 Foot Locker has gotten hit hard, stock looks like a buy, Barron's says 03/02/22 Fanatics valued at $27B in latest fundraising, WSJ reports FL Foot Locker $31.52 / +1.22 (+4.03%) 05/20/22 What You Missed On Wall Street On Friday 05/20/22 What You Missed On Wall Street This Morning 05/20/22 Fly Intel: Pre-market Movers 03/28/22 What You Missed On Wall Street On Monday 05/24/22 6th Annual Future of the Consumer: Sustainable Growth for a New Ecosystem 08/19/22 Foot Locker - FL FL Foot Locker $31.52 / +1.22 (+4.03%) 05/20/22 Unusually active option classes on open May 20th 04/20/22 Foot Locker call volume above normal and directionally bullish 03/04/22 Foot Locker put volume heavy and directionally bearish 02/23/22 Unusually active option classes on open February 23rd

Recommendations	Sinclair Broadcast price target lowered to $28 from $31 at Deutsche Bank » 07:15 05/23/22 05/23 07:15 05/23/22 07:15 SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 05/11/22 Sinclair Broadcast names Ryan Moore CRO, SVP of digital sales and sports 05/04/22 Sinclair Broadcast sees FY22 capital expenditures $98M-$108M 04/21/22 Sinclair Broadcast to offer HDR content for Bally Sports networks in Q3 04/14/22 Sinclair Broadcast, Charter reach comprehensive distribution agreement SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 05/05/22 Wells Fargo Wells Fargo upgrades Sinclair Broadcast to Overweight, raises target to $33 05/05/22 Wells Fargo Sinclair upgraded to Overweight from Equal Weight at Wells Fargo 04/26/22 EF Hutton Sinclair Broadcast initiated with a Buy at EF Hutton 04/19/22 Rosenblatt Sinclair Broadcast initiated with a Neutral at Rosenblatt SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 05/04/22 Sinclair Broadcast sees Q2 revenue $828M-$847M, consensus $1.64B 05/04/22 Sinclair Broadcast reports Q1 EPS $35.39, consensus $1.07 04/11/22 Sinclair Broadcast backs Broadcast segment Media revenues view of $709M-$725M 02/23/22 Sinclair Broadcast sees Q1 revenue $1.52B-$1.54B, consensus $1.52B SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 01/10/22 Sinclair nears deal to carry NBA games on streaming app, Bloomberg reports SBGI Sinclair Broadcast $25.19 / -0.59 (-2.29%) 05/05/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/26/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/11/22 What You Missed On Wall Street On Monday 01/10/22 Wall Street in Fives - Must Read Lists for Monday 06/09/22 Sinclair Broadcast Group Inc.
Recommendations	Momentus named short-term buy idea at Deutsche Bank » 07:14 05/23/22 05/23 07:14 05/23/22 07:14 MNTS Momentus $2.91 / +0.11 (+3.94%) Deutsche Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events Options MNTS Momentus $2.91 / +0.11 (+3.94%) 05/12/22 Momentus completes integration of Vigoride on SpaceX Falcon 9 05/05/22 Momentus completes all regulatory milestones for inaugural mission 04/29/22 Momentus receives FCC license for first flight 04/07/22 Momentus signs launch service agreements with SpaceX MNTS Momentus $2.91 / +0.11 (+3.94%) 05/11/22 Deutsche Bank Momentus price target lowered to $7 from $8 at Deutsche Bank 03/23/22 Deutsche Bank SpaceX decision 'clear positive' for Momentus, says Deutsche Bank 01/10/22 Deutsche Bank Momentus initiated with a Buy at Deutsche Bank MNTS Momentus $2.91 / +0.11 (+3.94%) 04/07/22 Fly Intel: Pre-market Movers 11/30/21 Fly Intel: After-Hours Movers 05/31/22 Momentus Inc MNTS Momentus $2.91 / +0.11 (+3.94%) 05/10/22 Momentus options imply 11.4% move in share price post-earnings 04/20/22 Largest borrow rate increases among liquid names 04/07/22 Unusually active option classes on open April 7th 12/16/21 Largest borrow rate increases among liquid names
Hot Stocks	Alnylam announces new results from 18-month analysis of HELIOS-A study » 07:14 05/23/22 05/23 07:14 05/23/22 07:14 ALNY Alnylam $132.40 / +2.98 (+2.30%) Alnylam announced new… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events ALNY Alnylam $132.40 / +2.98 (+2.30%) 04/04/22 FDA extends review timeline for Alnylam's vutrisiran NDA to treat ATTR amyloidos 04/01/22 Alnylam up 3%, strength attributed to conference cancellation speculation 03/17/22 Alnylam files patent infringement suits against Pfizer and Moderna 03/07/22 ProQR Therapeutics appoint Maraganore as strategic advisor to supervisory board ALNY Alnylam $132.40 / +2.98 (+2.30%) 05/02/22 H.C. Wainwright Alnylam price target raised to $430 from $400 at H.C. Wainwright 04/29/22 Citi Alnylam price target lowered to $211 from $223 at Citi 04/25/22 Morgan Stanley Alnylam downgraded to Equal Weight from Overweight at Morgan Stanley 04/12/22 H.C. Wainwright Alnylam price target raised to $400 from $350 at H.C. Wainwright ALNY Alnylam $132.40 / +2.98 (+2.30%) 04/28/22 Alnylam reports Q1 EPS ($2.00), consensus ($1.84) 02/10/22 Alnylam reports Q4 EPS ($1.69), consensus ($1.54) 02/10/22 Alnylam reports Q4 EPS ($1.69), consensus ($1.54) 01/09/22 Alnylam sees preliminary FY21 combined product revenues $662M ALNY Alnylam $132.40 / +2.98 (+2.30%) 03/17/22 What You Missed On Wall Street On Thursday 03/17/22 What You Missed On Wall Street This Morning 01/21/22 Fly Intel: Pre-market Movers 12/27/21 Wall Street in Fives - Must Read Lists for Monday 07/14/22 Extended PDUFA Date for Vutrisiran 10/06/22 PDUFA Date for Oxlumo (Lumasiran)
Hot Stocks	Power Solutions introduces turbo charge air cooled 8.8-liter engine » 07:13 05/23/22 05/23 07:13 05/23/22 07:13 PSIX Power Solutions $2.00 / +0.45 (+29.03%) Power Solutions… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News PSIX Power Solutions $2.00 / +0.45 (+29.03%) 04/13/22 Power Solutions' 6.0-liter industrial mobile engine receives EPA certification 03/28/22 Power Solutions announces extension to credit agreement 03/08/22 Power Solutions, Baudouin enter into international distribution agreement 03/07/22 Power Solutions to showcase 8.8 liter Power Systm engine during show
Recommendations	Corteva price target raised to $69 from $61 at Argus » 07:12 05/23/22 05/23 07:12 05/23/22 07:12 CTVA Corteva $59.21 / +0.21 (+0.36%) Argus analyst Bill… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly CTVA Corteva $59.21 / +0.21 (+0.36%) 05/13/22 Starboard takes stake in Humana, exits System1 04/04/22 Pacific Biosciences enters agricultural collaboration with Corteva Agriscience 03/24/22 Marrone Bio signs agreement with Corteva Agriscience 03/08/22 Corteva opens seed research station in Navasota, Texas CTVA Corteva $59.21 / +0.21 (+0.36%) 05/10/22 Deutsche Bank Corteva price target raised to $64 from $56 at Deutsche Bank 05/06/22 JPMorgan Corteva downgraded to Neutral on valuation at JPMorgan 05/06/22 JPMorgan Corteva downgraded to Neutral from Overweight at JPMorgan 04/29/22 Mizuho Corteva price target raised to $67 from $60 at Mizuho CTVA Corteva $59.21 / +0.21 (+0.36%) 05/04/22 Corteva raises FY22 operating EPS view to $2.35-$2.55 from $2.30-$2.50 05/04/22 Corteva reports Q1 adjusted EPS 97c, consensus 82c 02/02/22 Corteva sees FY22 adjusted EPS $2.30-$2.50, consensus $2.59 02/02/22 Corteva reports Q4 adjusted EPS 8c, consensus 9c CTVA Corteva $59.21 / +0.21 (+0.36%) 05/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/02/22 Fly Intel: After-Hours Movers

Earnings	Gilat Satellite reaffirms 2022 revenue view $245M-$265M » 07:12 05/23/22 05/23 07:12 05/23/22 07:12 GILT Gilat Satellite $6.74 / -0.095 (-1.39%) The company reiterated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events GILT Gilat Satellite $6.74 / -0.095 (-1.39%) 04/27/22 Gilat selected by Intelsat to provide satellite cellular backhaul solution 03/17/22 Gilat Satellite ESA for IFC achieves 'breakthrough' during Airbus flight tests 03/14/22 Gilat Satellite announces multimillion-dollar order for SkyEdge IV Taurus modems 02/28/22 TIM Brasil reaches over 1,000 sites leveraging Gilat platform GILT Gilat Satellite $6.74 / -0.095 (-1.39%) 07:11 Today Gilat Satellite reports Q1 EPS (4c) vs. (9c) last year 02/15/22 Gilat Satellite sees 2022 revenue $245M-$265M, one est. $258.71M 02/15/22 Gilat Satellite reports Q4 EPS 10c, one est. 5c GILT Gilat Satellite $6.74 / -0.095 (-1.39%) 01/03/22 Wall Street in Fives - Must Read Lists for Monday 01/03/22 Wall Street in Fives - Must Read Lists at Midday 09:30 Today Gilat Satellite - GILT
Hot Stocks	uCloudlink announces changes of independent registered public accounting firm » 07:12 05/23/22 05/23 07:12 05/23/22 07:12 UCL uCloudlink $1.14 / + (+0.00%) uCloudlink announced,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News UCL uCloudlink $1.14 / + (+0.00%) 05/09/22 uCloudlink provides update on status under HFCAA 05/09/22 uCloudlink provisionally identified by SEC as Commission-Identified Issuer 04/27/22 uCloudlink files 2021 annual report
Hot Stocks	GameStop launches wallet for cryptocurrencies and NFTs » 07:12 05/23/22 05/23 07:12 05/23/22 07:12 GME GameStop $95.85 / -3.28 (-3.31%) GameStop announced it… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GME GameStop $95.85 / -3.28 (-3.31%) 05/16/22 GameStop names Nir Patel as COO, effective May 31 05/13/22 U.S. video game spending fell 8% y/y in April, says NPD 05/13/22 GameStop rises 18.2% 05/12/22 GameStop, AMC, Bed Bath & Beyond rise as 'meme stocks' see momentum GME GameStop $95.85 / -3.28 (-3.31%) 03/28/22 B. Riley Bed Bath & Beyond price target raised to $26 from $19 at B. Riley 03/18/22 Wedbush GameStop price target lowered to $30 from $45 at Wedbush 03/08/22 BofA Bed Bath's buybuy BABY 'not worth' several billion dollars, says BofA 01/19/22 Jefferies GameStop price target lowered to $100 from $145 at Jefferies GME GameStop $95.85 / -3.28 (-3.31%) 03/17/22 GameStop reports Q4 EPS ($1.94) vs $1.19 last year 03/17/22 Notable companies reporting after market close 12/08/21 GameStop reports Q3 adjusted EPS ($1.39), consensus (52c) 12/08/21 Notable companies reporting after market close GME GameStop $95.85 / -3.28 (-3.31%) 05/19/22 Former GameStop employee sues company over NY manual labor law, Polygon says 03/26/22 GameStop crypto dream 'a long shot,' Barron's says 03/06/22 Chewy co-founder Ryan Cohen takes large stake in Bed Bath & Beyond, WSJ says 01/07/22 Games analyst 'very skeptical' of GameStop's new plans GME GameStop $95.85 / -3.28 (-3.31%) 05/21/22 Short Report: Bearish bets increase in meme names GameStop and Carvana 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 04/05/22 What You Missed This Week in Video Games 06/02/22 GameStop Corp. GME GameStop $95.85 / -3.28 (-3.31%) 05/12/22 Unusually active option classes on open May 12th 04/01/22 Unusually active option classes on open April 1st 03/24/22 Unusually active option classes on open March 24th 03/24/22 Unusual call flow in option market yesterday
Earnings	Gilat Satellite reports Q1 EPS (4c) vs. (9c) last year » 07:11 05/23/22 05/23 07:11 05/23/22 07:11 GILT Gilat Satellite $6.74 / -0.095 (-1.39%) Reports Q1 revenue $51.4M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Events GILT Gilat Satellite $6.74 / -0.095 (-1.39%) 04/27/22 Gilat selected by Intelsat to provide satellite cellular backhaul solution 03/17/22 Gilat Satellite ESA for IFC achieves 'breakthrough' during Airbus flight tests 03/14/22 Gilat Satellite announces multimillion-dollar order for SkyEdge IV Taurus modems 02/28/22 TIM Brasil reaches over 1,000 sites leveraging Gilat platform GILT Gilat Satellite $6.74 / -0.095 (-1.39%) 02/15/22 Gilat Satellite sees 2022 revenue $245M-$265M, one est. $258.71M 02/15/22 Gilat Satellite reports Q4 EPS 10c, one est. 5c GILT Gilat Satellite $6.74 / -0.095 (-1.39%) 01/03/22 Wall Street in Fives - Must Read Lists for Monday 01/03/22 Wall Street in Fives - Must Read Lists at Midday 09:30 Today Gilat Satellite - GILT
Hot Stocks	IDEX Biometrics announces subscription rights exercise » 07:10 05/23/22 05/23 07:10 05/23/22 07:10 IDBA IDEX Biometrics $9.69 / + (+0.00%) The board of directors of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research IDBA IDEX Biometrics $9.69 / + (+0.00%) 05/13/22 IDEX Biometrics ASA (ADS) trading resumes 05/13/22 IDEX Biometrics ASA (ADS) trading halted, volatility trading pause 02/24/22 IDEX Biometrics ASA (ADS) trading resumes 02/24/22 IDEX Biometrics ASA (ADS) trading halted, volatility trading pause IDBA IDEX Biometrics $9.69 / + (+0.00%) 10/13/21 Northland IDEX Biometrics initiated with an Outperform at Northland

Hot Stocks	AstraZeneca's Vaxzevria approved in EU as third dose booster for COVID-19 » 07:10 05/23/22 05/23 07:10 05/23/22 07:10 AZN AstraZeneca $66.23 / +1.68 (+2.60%) AstraZeneca's… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AZN AstraZeneca $66.23 / +1.68 (+2.60%) 05/19/22 CHMP recommends authorizing AstraZeneca COVID vaccine booster for adults 05/15/22 AstraZeneca presents full results from MANDALA Phase III trial 05/12/22 AstraZeneca joins Accumulus Synergy as sponsor 05/05/22 AstraZeneca's Enhertu approved in U.S. in HER2-positive breast cancer AZN AstraZeneca $66.23 / +1.68 (+2.60%) 05/18/22 Kepler Cheuvreux AstraZeneca downgraded to Hold from Buy at Kepler Cheuvreux 04/21/22 Morgan Stanley AstraZeneca price target raised to 11,100 GBp from 10,200 GBp at Morgan Stanley 04/14/22 Barclays AstraZeneca price target raised to 12,000 GBp from 11,500 GBp at Barclays 04/12/22 Piper Sandler Schrodinger has 'potent and highly selective' molecule , says Piper Sandler AZN AstraZeneca $66.23 / +1.68 (+2.60%) 04/29/22 AstraZeneca backs FY22 core EPS up by mid to high twenties percentage 04/29/22 AstraZeneca reports Q1 core EPS $1.89, up 20% y/y 02/10/22 AstraZeneca sees FY22 core EPS up by mid to high twenties percentage 02/10/22 AstraZeneca reports Q4 core EPS $1.67, two estimates 73c AZN AstraZeneca $66.23 / +1.68 (+2.60%) 05/10/22 Emergent plant's quality problems led to 400M discarded vaccines, WSJ reports 03/23/22 AstraZeneca preventive COVID shot set to win EU clearance, Reuters says 12/23/21 Nigeria destroys 1M expired AstraZeneca vaccine doses, Reuters reports 12/22/21 U.S. in talks to buy more of AstraZeneca COVID prevention drug, Bloomberg says AZN AstraZeneca $66.23 / +1.68 (+2.60%) 04/06/22 Fly Intel: Pre-market Movers 03/23/22 What You Missed On Wall Street On Wednesday 03/23/22 What You Missed On Wall Street This Morning 01/13/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today 8th Annual Berenberg Conference USA 2022 06/03/22 2022 ASCO Annual Meeting 06/20/22 AstraZeneca AZN AstraZeneca $66.23 / +1.68 (+2.60%) 04/26/22 AstraZeneca call volume above normal and directionally bullish 04/07/22 AstraZeneca put volume heavy and directionally bearish 03/03/22 AstraZeneca put volume heavy and directionally bearish 03/01/22 Unusually active option classes on open March 1st
Hot Stocks	Verano reports dismissal of all claims in Nielsen arbitration » 07:09 05/23/22 05/23 07:09 05/23/22 07:09 VRNOF Verano Holdings $7.52 / +0.47 (+6.67%) The company said,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly VRNOF Verano Holdings $7.52 / +0.47 (+6.67%) 05/19/22 Verano Holdings announces opening of MUV Ocala 05/16/22 Verano Holdings launches mobile applications, rewards programs 05/02/22 Verano receives permission to file financials, withdraws MCTO application 04/29/22 Verano Holdings announces opening of 45th Florida cannabis dispensary VRNOF Verano Holdings $7.52 / +0.47 (+6.67%) 04/28/22 Canaccord Verano Holdings price target lowered to C$24.50 from C$26 at Canaccord 02/11/22 Alliance Global Partners Verano Holdings initiated with a Buy at Alliance Global Partners 02/09/22 Needham Verano Holdings initiated with a Buy at Needham 02/01/22 Craig-Hallum Goodness Growth downgraded to Hold from Buy at Craig-Hallum VRNOF Verano Holdings $7.52 / +0.47 (+6.67%) 04/27/22 Verano Holdings reports Q4 revenue $211M, consensus $299.39M VRNOF Verano Holdings $7.52 / +0.47 (+6.67%) 02/03/22 Rising High: Verano Holdings to buy Goodness Growth in $413M transaction
Hot Stocks	Builders FirstSource releases inaugural CSR report » 07:09 05/23/22 05/23 07:09 05/23/22 07:09 BLDR Builders FirstSource $60.85 / -1.83 (-2.92%) Builders FirstSource… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BLDR Builders FirstSource $60.85 / -1.83 (-2.92%) 05/10/22 Builders FirstSource board authorizes new $2B share buyback program 05/10/22 Builders FirstSource sees FY CapEx $375M-$400M 03/07/22 Builders FirstSource hires Messersmith as Chief People Officer 03/04/22 Builders FirstSource director Sherman sells 30,000 common shares BLDR Builders FirstSource $60.85 / -1.83 (-2.92%) 05/17/22 BMO Capital Builders FirstSource price target lowered to $90 from $96 at BMO Capital 05/13/22 Wedbush Builders FirstSource price target raised to $110 from $105 at Wedbush 05/11/22 RBC Capital Builders FirstSource price target lowered to $93 from $106 at RBC Capital 04/06/22 B. Riley Builders FirstSource downgraded to Neutral at B. Riley on demand uncertainty BLDR Builders FirstSource $60.85 / -1.83 (-2.92%) 05/10/22 Builders FirstSource reports Q1 adjusted EPS $3.90, consensus $1.98 05/09/22 Notable companies reporting before tomorrow's open 05/09/22 Notable companies reporting before tomorrow's open 03/01/22 Builders FirstSource reports Q4 adjusted EPS $2.78, consensus $1.91 05/25/22 22nd Annual Institutional Investor Conference 06/14/22 Builders FirstSource, Inc.
Hot Stocks	Flora Growth acquires CBD Brand Masaya, no terms » 07:09 05/23/22 05/23 07:09 05/23/22 07:09 FLGC Flora Growth $1.06 / -0.18 (-14.52%) Flora Growth announced … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly FLGC Flora Growth $1.06 / -0.18 (-14.52%) 05/12/22 Flora Growth establishes on-the-ground presence in UK and EU 05/11/22 Flora Growth launches Vessel in Canada, signs deal with Ontario Cannabis Store 03/23/22 Flora Growth to expand presence in Europe with Greenyard, JustCBD pact 03/17/22 Cannabis company Flora Growth names CEO Luis Merchan Chairman of the Board FLGC Flora Growth $1.06 / -0.18 (-14.52%) 10/13/21 Roth Capital Flora Growth initiated with a Buy at Roth Capital 08/20/21 MKM Partners Flora Growth price target raised to $11.50 from $6.00 at MKM Partners 06/23/21 MKM Partners MKM Partners starts Flora Growth with Buy given its discount potential 06/22/21 MKM Partners Flora Growth initiated with a Buy at MKM Partners FLGC Flora Growth $1.06 / -0.18 (-14.52%) 05/10/22 Flora Growth reiterates 2022 revenue view $35M-$45M 05/10/22 Flora Growth reports 2021 revenue $9M vs. $0.1M in 2020 19 Nov FLGC Flora Growth $1.06 / -0.18 (-14.52%) 02/24/22 Rising High: Clever Leaves expands partnership with German distributor 12/02/21 Rising High: ATAI Life Sciences increases ownership in COMPASS Pathways
Initiation	Ouster initiated with an Overweight at Cantor Fitzgerald » 07:09 05/23/22 05/23 07:09 05/23/22 07:09 OUST Ouster $2.37 / -0.095 (-3.85%) Cantor Fitzgerald analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options OUST Ouster $2.37 / -0.095 (-3.85%) 03/23/22 Ouster, Tacticaware launch joint security solution 03/03/22 Ouster in strategic customer pact with Third Wave Automation 01/20/22 Ouster in multi-year lidar pact with autonomous delivery firm Serve Robotics 01/11/22 Ouster, Vecna Robotics team amid acceleration of material handling automation OUST Ouster $2.37 / -0.095 (-3.85%) 06:28 Today Cantor Fitzgerald Ouster initiated with an Overweight at Cantor Fitzgerald 03/31/22 Chardan Ouster initiated with a Buy at Chardan 02/16/22 Citi Ouster price target lowered to $17 from $19 at Citi 02/08/22 Craig-Hallum Velodyne stock 60% outperformance 'seems an overreaction,' says Craig-Hallum OUST Ouster $2.37 / -0.095 (-3.85%) 05/03/22 Ouster backs FY22 revenue view $65M-$85M, consensus $74.67M 05/03/22 Ouster reports Q1 EPS (19c), consensus (16c) 02/15/22 Ouster reports Q4 EPS (17c), consensus (15c) OUST Ouster $2.37 / -0.095 (-3.85%) 02/15/22 Fly Intel: After-Hours Movers 05/25/22 22nd Annual Institutional Investor Conference 06/09/22 Ouster Inc OUST Ouster $2.37 / -0.095 (-3.85%) 02/15/22 Ouster Inc options imply 16.3% move in share price post-earnings

Events

Earnings calls, analyst events, roadshows and more

XPEV
Today at 08:00

XPeng - XPEV Conference Calls
NIU
Today at 08:00

Niu Technologies - NIU Conference Calls
CAAS
Today at 08:00

China Automotive - CAAS Conference Calls
CSTE
Today at 08:00

Caesarstone Firm Sponsored Meetings

Virtual Meeting
JPM
Today at 08:00

JPMorgan Firm Sponsored Meetings

Virtual Meeting
Today at 08:30

Chicago Fed National Activity Index: April 2022 Government Event
Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: April 2022 Government Event
RSLS
Today at 08:30

ReShape Lifesciences - RSLS Conference Calls
AVPT
Today at 09:00

AvePoint Firm Sponsored Meetings

Virtual Meeting
GILT
Today at 09:30

Gilat Satellite - GILT Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Carlyle Group mulls sale of Titan acquisition, Bloomberg reports

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access